z-logo
Premium
Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection
Author(s) -
PérezAisa M. A.,
Del Pino D.,
Siles M.,
Lanas A.
Publication year - 2005
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2004.02297.x
Subject(s) - medicine , helicobacter pylori , incidence (geometry) , medical prescription , peptic , gastroenterology , population , helicobacter pylori infection , peptic ulcer , proton pump inhibitor , epidemiology , prevalence , pharmacology , environmental health , optics , physics
Summary Background : It is unknown whether the incidence of peptic ulcer changes in areas with a high prevalence of Helicobacter pylori infection. Aim : To determine trends in peptic ulcer complications in a community with a high prevalence of H. pylori infection. Methods : New endoscopic diagnoses of peptic ulcers and their complications from 1985 to 2000 were obtained. H. pylori infection in the adult population, the number of prescriptions for anti‐secretory drugs and non‐steroidal anti‐inflammatory drugs were also evaluated. Results : Although the global prevalence of H. pylori infection remains high in this population (>60%), a 41.4 to 25.4% decrease in the incidence of peptic ulcers and ulcer complications was observed. This was associated with a decrease in the prevalence of H. pylori infection in people under 65 years of age, a 3.5‐fold increase in the number of prescriptions of proton‐pump inhibitors and an increase in the number of prescriptions of non‐steroidal anti‐inflammatory drugs, especially coxibs. Conclusions : In an area with a high prevalence of H. pylori infection, the incidence of peptic ulcer and associated complications is declining rapidly. This was associated with a reduction of the prevalence of H. pylori infection in the young and a widespread use of proton‐pump inhibitors. The increase in the use of non‐steroidal anti‐inflammatory drugs, especially coxibs, has not changed the tendency.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here